Skip to content

Study · Not a test of the peptide alone · 2001

1 result

Generation of growth hormone pulsatility in women: evidence against somatostatin withdrawal as pulse initiator.

Dimaraki EV, Jaffe CA, Demott-Friberg R, Russell-Aulet M, Bowers CY, Marbach P, Barkan AL

American journal of physiology. Endocrinology and metabolism1 Mar 2001Cited by 17 (Europe PMC)

PMID11171604 (opens in a new tab)DOI10.1152/ajpendo.2001.280.3.e489 (opens in a new tab)PepBankPUB-11171604
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking GHRP-6.

  1. 01HumanNot a test of GHRP-6 aloneNon-randomized trialMechanism

    In postmenopausal women, octreotide did not affect the GH response to GHRP‑6 challenge.

    In plain wordsIn postmenopausal women, octreotide did not change the growth hormone response to GHRP‑6 compared with saline.

    Peptide
    GHRP-6
    Outcome
    No significant changeGH response to GHRP-6 during octreotide infusion
    Study

    n = 6

    Comparator
    normal saline infusion
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones

    Source sentences

    Summary
    The response of GH to GH-releasing hormone (GHRH) was not suppressed, and the GH response to GH-releasing peptide-6 (GHRP-6) was unaffected.
    1 context sentence
    Summary · context
    Six healthy postmenopausal women (age 67 +/- 3 yr, body mass index 24.7 +/- 1.2 kg/m(2)) were studied during normal saline and octreotide infusion providing stable plasma octreotide levels of 2,567 +/- 37 pg/ml.

    In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking GHRP-6.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:13 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.